At the end of the course, participants should be able to:
1. Identify major predictive markers in oncologic pathology
2. Identify most common clinical applications of immunohistochemistry in surgical pathology
3. Identify most common clinical application of FISH in surgical pathology
4. Identify sources of technical and interpretation pitfalls in diagnostic immunohistochemistry
5. Define immunophenotypes of various organ-related tumors
6. Interpret the most common FISH tests in anatomic pathology

Speakers

Stanley Hamilton, M.D.
Director, Pathology and Laboratory Medicine, The University of Texas,
M.D. Anderson Cancer Center, Houston, Texas, USA

Elizabeth Hammond, M.D.
Anatomic Pathology, Utah Pathology Services Inc., Department of
Pathology, LDS Hospital, Salt Lake City, UT, USA

William Travis, M.D.
Director, Thoracic Pathology Fellowship Program,
Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Mahul Amin, M.D.
Chairman, Pathology and Laboratory Medicine,
Cedars-Sinai Medical Center, LA, CA, USA;
Professor of Pathology, David Geffen School of Medicine at UCLA, LA, CA, USA;
Chairman, Cancer Committee of the College of American Pathologists

Clive Taylor, M.D., D. Phil
Professor and Chair, Department of Pathology, Senior Associate Dean,
Educational Affairs, University of Southern California, Los Angeles, CA, USA;
Editor-in-Chief, Journal of Applied Immunohistochemistry and Molecular Morphology

David Hicks, M.D.
Director, Surgical Pathology, Department of Pathology,
University of Rochester, Rochester, NY, USA

Todd S. Barry, M.D., Ph.D.
Medical Director, Clarient, Inc, Aliso Viejo, CA, USA

Stephen Hewitt, M.D., Ph.D.
Clinical Investigator and Chief, Tissue Array Research Program (TARP)
Advanced Technology Center, NCI/NIH, Bethesda, MD, USA

Bryan Hewlett, ART, MLT
Quality Management Program, Laboratory Services,
Ontario Medical Association, Toronto, ON, Canada

Richard Cartun, Ph.D.
Director of Immunopathology, Co-Director, Anatomic Pathology,
Department of Pathology, Hartford Hospital, Hartford, CT, USA

Richard Eisen, M.D.
Associate Clinical Professor of Pathology, Yale University;
Attending Pathologist, Greenwich Hospital, Greenwich, CT, USA

Steve Potts, Ph.D, MBA
CEO and Chairman, Flagship BioSciences, LLC, Flagstaff, AZ, USA

David Young, DVM, DACVP, DABT
President, Flagship BioSciences, LLC, Flagstaff, AZ, USA;
Founding Director, Directorate of Toxicology, US Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD, USA;
Director, Toxicology, Spring Valley Laboratory, Woodline, MD, USA

Serhan Alkan, M.D.
Director of Hematopathology and Molecular Diagnostics,
Vitro Molecular Laboratories, LLC, Miami, FL, USA

Hadi Yaziji, M.D.
Medical Director, Vitro Molecular Laboratories, Miami, FL, USA;
Adjunct Assistant Professor, MD Anderson Cancer Center, Houston, TX, USA;
Clinical  Assistant Professor, University of British Columbia, Vancouver, BC, Canada

For more information you may visit: http://www.pathlearning.com/The_Fifth_Annual_International_Retreat_on_Applied_Immunohistochemistry_and_Molecular_Morphology/Index.html

You can also contact at: CMEcourses@gmail.com